Octave Specialty Group earnings date
Octave Specialty Group (FGPN) Q3 2026 Earnings Report
DE:FGPN Q3 2026 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- -EUR 0.04
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.19
DE:FGPN Q3 2026 Revenue Results
- Actual Revenue
- EUR 77.42M
- Expected Revenue
- EUR 21.06M
- Beat/Miss
- Beat by +EUR 56.36M
- YoY Revenue Growth
- +28.13%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/09/2026
- Time
- After Close
- Conference Call
- Monday, November 9, 2026
Octave Specialty Group's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was predominantly positive. Strong Insurance Distribution organic growth, EBITDA and margin expansion, improving Everspan underwriting results, cost reductions, technology deployment and reduced leverage significantly outweighed the cited challenges, including a softening P&C market, energy exposure, Everspan's elevated expense and combined ratios, and the possibility that Everspan gross premiums will come in slightly under guidance.
For 2026, Octave continues to expect double-digit organic growth in the fourth quarter, is firmly on track to exceed its full year organic growth guidance of 25% plus, expects to exceed its $45 million Insurance Distribution adjusted EBITDA guidance, and expects Everspan’s full year gross premiums written may come in slightly under its $410 million guidance but is well positioned to meet or beat its full year adjusted EBITDA guidance of $6 million; adjusted corporate expenses remain well positioned relative to the full year outlook of approximately $29.5 million, and 2026 is expected to be the first year of positive adjusted net income per share, in line with or better than guidance, while the company maintains confidence in achieving its target consolidated adjusted EBITDA to shareholders of $80 million in 2028, expects 2027 capacity to be oversubscribed, and expects Everspan’s fourth-quarter growth to be in line to better than third quarter.
- Strong Insurance Distribution Revenue and Organic GrowthInsurance Distribution total revenue grew 35% in the third quarter to $58 million, driven by 23% organic growth and the October 2025 acquisition of ArmadaCare. Year-to-date organic growth was just over 35%, and the company expects to exceed its full-year organic growth guidance of 25% plus.
- Insurance Distribution EBITDA and Margin ExpansionYear-to-date Insurance Distribution adjusted EBITDA to shareholders nearly tripled to $43.4 million, while margins expanded almost 9 percentage points to 22.2%. Third-quarter adjusted EBITDA rose nearly 40% to $8.3 million from $6 million, and the related margin increased to 14.2% from 13.9%.
- Insurance Distribution EBITDA Guidance Expected to Be ExceededThe company expects to exceed its $45 million Insurance Distribution adjusted EBITDA guidance for 2026. Year-to-date adjusted EBITDA had reached $43 million by the end of the third quarter.
- Broad-Based Improvement in Consolidated ResultsThird-quarter consolidated results improved year-over-year across every key measure. Net loss to shareholders narrowed to $13.8 million, or $0.31 per share, from $31.7 million, or $0.65 per share, an improvement of $17.9 million or $0.34 per share. Adjusted EBITDA to shareholders improved to $3.3 million from negative $2.9 million, while the adjusted net loss narrowed to $1.3 million, or $0.03 per share, from $10 million, or $0.21 per share.
- Everspan Profitability and Premium GrowthEverspan generated third-quarter adjusted EBITDA to shareholders of $2.2 million compared with less than $0.1 million in the prior-year period, and net income of $1.3 million. Net premiums written increased 44% and net premiums earned increased 52%. Everspan now supports 30 programs, up from 25 a year ago.
- Everspan Loss Ratio and Underwriting ImprovementEverspan's third-quarter combined ratio improved to 100.6% from 112.9%, driven by a lower loss ratio of 57.1% versus 84.5% a year ago. On an accident-year basis, the loss ratio improved by 680 basis points to 54.5%, reflecting the repositioning of the portfolio toward new programs with lower expected loss ratios. The pro forma year-to-date combined ratio improved sequentially to 96.7% from 97.1%.
- Everspan Adjusted EBITDA OutlookEverspan produced third-quarter pretax income of $1.4 million and adjusted EBITDA of $2.2 million, both improved from breakeven results in the prior-year quarter. Year-to-date adjusted EBITDA was $5.6 million, more than double the first nine months of 2025, and the company believes Everspan is positioned to meet or beat its full-year adjusted EBITDA guidance of $6 million.
- Growth Through Product Adjacencies and Bolt-On TeamsThe company launched three new programs in recent weeks and seven product adjacencies in the U.S. year-to-date, leveraging existing infrastructure, distribution relationships and underwriting talent. Future organic growth is expected to be supported by bolt-on team launches and adjacent products within existing platforms.
- Accident & Health Portfolio Provides DiversificationAccident & Health represents about one-third of the Insurance Distribution portfolio and provides a buffer against current P&C market headwinds. The businesses are benefiting from expanded distribution relationships, strong retention and favorable pricing, while premiums and organic growth are increasing, including at ArmadaCare.
- Double-Digit A&H Pricing and Favorable PerformanceAccident & Health pricing continues to be a tailwind, with double-digit rate increases due to surging health care costs. Management said the A&H portfolios have generally performed in line with, or slightly better than, the expectations of carrier capacity partners, with the strong rate environment benefiting loss ratios.
- Strong Pipeline and 2027 Capacity PositionThe company continues to see a strong pipeline of start-up MGA opportunities, particularly in the U.S. and also in Europe. Management said 2027 capacity is largely lined up and is expected to be oversubscribed, driven in large part by the company's track record of profitable and less volatile underwriting results.
- Everspan Portfolio Diversification and PWIC SaleEverspan has begun selectively expanding into package and non-catastrophe property programs to complement its casualty book and create a more balanced portfolio. The planned sale of Providence Washington Insurance Company is expected to simplify the operating structure, strengthen rating agency capital and tangible book value, and, upon closing, generate a consolidated net gain of close to $4 million and increase Everspan's tangible book value by approximately $11 million.
- Corporate Cost ReductionThird-quarter corporate expenses declined to $10 million from $27 million a year ago. Adjusted corporate expenses fell more than 20% to $7.3 million from $9.5 million, while year-to-date adjusted corporate expenses declined roughly 20% to $22.5 million from $28.4 million. The company remains positioned relative to its full-year outlook of approximately $29.5 million.
- AI and Technology Deployment Across MGAsAll MGAs are now on their target technology platforms, and rollout of AI-driven intake across the U.S. MGAs is largely complete. Management said the initiatives are accelerating submission vetting and increasing underwriting velocity, with the potential to improve operating leverage in the future.
- Operating Model and Technology Savings InitiativesThe new corporate target operating model implemented in the fourth quarter of last year materially reduced the 2026 run-rate cost base. The company is exploring further savings for 2027, continuing global integration and planning the initial phase of a target operating model for international operations later in the year.
- Improved Leverage and Positive Earnings MilestoneAt September 30, the net leverage ratio calculated under the credit facilities was below 3x, providing greater flexibility for strategic initiatives including minority-interest buy-ins and noncore asset sales. The company remains on track for 2026 to be the first year it expects to deliver positive adjusted net income per share.
- Long-Term Growth and Earnings TargetsManagement said the company is well positioned to meet or exceed key 2026 guidance metrics and believes Insurance Distribution is poised to maintain sector-leading growth. The company remains confident in achieving its target consolidated adjusted EBITDA to shareholders of $80 million in 2028.
- Attractive Casualty SME and Alternative Market OpportunitiesCasualty SME classes, including general liability and select specialty classes, continue to achieve rate increases ranging from mid-single to double digits and were described as attractive opportunities for growth. Alternative classes are showing low correlation to broader P&C markets, with rates holding firm.
DE:FGPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.08- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.04-0.03 | -0.19 | 85.71% (+0.16) | |
| Aug 06, 2026 | 2026 (Q2) | -0.00-0.04 | -0.2 | 81.82% (+0.16) | |
| May 06, 2026 | 2026 (Q1) | 0.030.34 | -0.12 | 384.62% (+0.45) | |
| Feb 23, 2026 | 2025 (Q4) | -0.13-0.02 | -0.11 | 83.33% (+0.09) | |
| Nov 10, 2025 | 2025 (Q3) | -0.18-0.19 | -0.42 | 54.35% (+0.23) | |
| Aug 07, 2025 | 2025 (Q2) | -0.17-0.20 | 0.16 | -222.22% (-0.36) | |
| May 12, 2025 | 2025 (Q1) | -0.06-0.12 | 0.74 | -115.85% (-0.86) | |
| Feb 26, 2025 | 2024 (Q4) | 0.00-0.11 | 0.29 | -137.50% (-0.40) | |
| Nov 12, 2024 | 2024 (Q3) | 0.08-0.42 | 1.81 | -123.00% (-2.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


